Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncology

28 Jun 2013

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Lung Cancer Treatments and Mutations
Share to Protein Degradation and Inhibitors

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 23810823
DOI: 10.1016/j.coph.2013.06.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncologyPMID 23810823Read ↗

Precision Oncology, Signaling Pathways Reprogramming and Targeted Therapy: A Holistic Approach to Molecular Cancer TherapeuticsSemantic proximity Read ↗

Kinase-targeted cancer therapies: progress, challenges and future directionsSemantic proximity Read ↗

Precision Oncology-Based Targeting of Signaling Pathways toward a Holistic Approach to Cancer TherapeuticsSemantic proximity Read ↗

Molecular Mechanisms of Cancer Drug Resistance: Emerging Biomarkers and Promising Targets to Overcome Tumor ProgressionSemantic proximity Read ↗

A genome-wide net to catch and understand cancer.Semantic proximity Read ↗

Twenty-First Century Precision Medicine in Oncology: Genomic Profiling in Patients With CancerSemantic proximity Read ↗

Kinase inhibitors for precision therapy of triple-negative breast cancer: Progress, challenges, and new perspectives on targeting this heterogeneous diseaseSemantic proximity Read ↗

Understanding the Genetic Mechanisms of Cancer Drug Resistance Using Genomic ApproachesSemantic proximity Read ↗

Advancements in Cancer TreatmentsSemantic proximity Read ↗

Drug resistance: origins, evolution and characterization of genomic clones and the tumor ecosystem to optimize precise individualized therapySemantic proximity Read ↗

Analysis of 10,478 cancer genomes identifies candidate driver genes and opportunities for precision oncology.Semantic proximity Read ↗

Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.